Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Dovetail wins Communiqué Agility and Flexibility award at Communiqué 2021

This inaugural award was given to Dovetail amid fierce competition from four other agencies

We are BOLD

BOLDSCIENCE marks its 1-year launch anniversary with record growth

Specialist medical communication agency BOLDSCIENCE has seen demand for its ‘scientifically creative’ service offerings soar over the past year as global pharma and biotech clients search for trusted partners with...

BOLDSCIENCE

Helping Caregivers Stay Organized, Secure, and Informed

Audrey Bond, Founder & CEO of Vaultt, discusses her inspiration behind founding the company, how Vaultt is revolutionizing data-sharing in Canada, common biosecurity and data privacy concerns, her experience with...

Impetus Digital

Transitioning to the “New Normal”: What This Means for Oncology Care

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US...

Impetus Digital

- PMLiVE

Sanofi boosts transplant portfolio with newly approved Rezurock

Sanofi’s acquisition of Kadmon Holdings adds Rezurock to its transplant portfolio in a deal worth $1.9bn.

- PMLiVE

bluebird bio gears up for split

The company has filled its coffers with $75m in new funding and hired new leaders to support its split into two separate companies, bluebird bio and 2seventy bio

- PMLiVE

Ovid wins Communiqué Small Consultancy of the Year award at Communiqué 2021

Ovid is an integrated public affairs, PR and patient advocacy agency

- PMLiVE

Future of MHRA uncertain amid Brexit-fuelled shake up

Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions

- PMLiVE

Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021

This highly coveted award was given to Oxford PharmaGenesis amid fierce competition from five other agencies

Roche Basel Switzerland

Roche bets on T-cell therapies with Adaptimmune deal

Genentech signs deal for five ‘off the shelf’ T-cell therapies and a personalised cell therapy platform in a deal potentially worth more than $3bn

- PMLiVE

DOVETAIL & IBD REGISTRY WIN AGILITY AND FLEXIBILITY AWARD AT COMMUNIQUÉ 2021

The award was the first to be won in Communiqué’s new AGILITY AND FLEXIBILITY category.

Dovetail

- PMLiVE

Tezepelumab effective in severe asthma with comorbid nasal polyps

Amgen’s novel drug offers hope to the one-in-five people with severe asthma who also have nasal polyps

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links